References
Rubner, J. Nature 382, 104 (1996).
Blaschke, G., Kraft, H. P., Fickentscher, K. & Köhler, F. Drug Res. 29, 1640–1642 (1979).
Scott, W. J., Fradkin, R. & Wilson, J. G. Teratology 16, 333–336 (1977).
Fabro, S., Smith, R. L. & Williams, R. T. Nature 2l5, 296 (1967).
Eriksson, T., Björkman, S., Roth, B., Fyge, A. & H¨glund, P. Chirality 7, 44–52 (1995).
Zwingenberger, K. & Wnendt, S. J. Inflammation 46, 177–211 (1996).
Wnendt, S. et al. Chirality 8, 390–396 (1996).
Büch, H. P., Omlor, G. & Knabe, J. Drug Res. 40, 32–36 (1990).
Heger, W. et al. Teratog. Carcinog. Mutagen. 14, 115–122 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wnendt, S., Zwingenberger, K. Thalidomide's chirality. Nature 385, 303–304 (1997). https://doi.org/10.1038/385303b0
Issue Date:
DOI: https://doi.org/10.1038/385303b0
- Springer Nature Limited
This article is cited by
-
3D-chiral (2.5) atom-based TOMOCOMD-CARDD descriptors: theory and QSAR applications to central chirality codification
Journal of Mathematical Chemistry (2008)
-
Ab initio calculation of molecular chiroptical properties
Theoretical Chemistry Accounts (2006)